252 related articles for article (PubMed ID: 24708360)
1. In vivo molecular imaging of HER2 expression in a rat model of Barrett's esophagus adenocarcinoma.
Realdon S; Dassie E; Fassan M; Dall'Olmo L; Hatem G; Buda A; Arcidiacono D; Diamantis G; Zhang H; Greene MI; Sturniolo GC; Rugge M; Alberti A; Battaglia G
Dis Esophagus; 2015; 28(4):394-403. PubMed ID: 24708360
[TBL] [Abstract][Full Text] [Related]
2. Detection of fluorescent organic nanoparticles by confocal laser endomicroscopy in a rat model of Barrett's esophageal adenocarcinoma.
Dassie E; Arcidiacono D; Wasiak I; Damiano N; Dall'Olmo L; Giacometti C; Facchin S; Cassaro M; Guido E; De Lazzari F; Marin O; Ciach T; Fery-Forgues S; Alberti A; Battaglia G; Realdon S
Int J Nanomedicine; 2015; 10():6811-23. PubMed ID: 26586943
[TBL] [Abstract][Full Text] [Related]
3. Utility of confocal laser endomicroscopy in identifying high-grade dysplasia and adenocarcinoma in Barrett's esophagus: a systematic review and meta-analysis.
Gupta A; Attar BM; Koduru P; Murali AR; Go BT; Agarwal R
Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):369-77. PubMed ID: 24535597
[TBL] [Abstract][Full Text] [Related]
4. Probe-based confocal laser endomicroscopy compared with standard four-quadrant biopsy for evaluation of neoplasia in Barrett's esophagus.
Bajbouj M; Vieth M; Rösch T; Miehlke S; Becker V; Anders M; Pohl H; Madisch A; Schuster T; Schmid RM; Meining A
Endoscopy; 2010 Jun; 42(6):435-40. PubMed ID: 20506064
[TBL] [Abstract][Full Text] [Related]
5. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma.
Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV
Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440
[TBL] [Abstract][Full Text] [Related]
6. In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy.
Kiesslich R; Gossner L; Goetz M; Dahlmann A; Vieth M; Stolte M; Hoffman A; Jung M; Nafe B; Galle PR; Neurath MF
Clin Gastroenterol Hepatol; 2006 Aug; 4(8):979-87. PubMed ID: 16843068
[TBL] [Abstract][Full Text] [Related]
7. Confocal laser endomicroscopy for in vivo diagnosis of Barrett's oesophagus and associated neoplasia: a pilot study conducted in a single Italian centre.
Trovato C; Sonzogni A; Ravizza D; Fiori G; Tamayo D; De Roberto G; de Leone A; De Lisi S; Crosta C
Dig Liver Dis; 2013 May; 45(5):396-402. PubMed ID: 23352281
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of laser marking in Barrett's esophagus with volumetric laser endomicroscopy: first-in-man pilot study.
Swager AF; de Groof AJ; Meijer SL; Weusten BL; Curvers WL; Bergman JJ
Gastrointest Endosc; 2017 Sep; 86(3):464-472. PubMed ID: 28161451
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma.
Hao Y; Triadafilopoulos G; Sahbaie P; Young HS; Omary MB; Lowe AW
Gastroenterology; 2006 Sep; 131(3):925-33. PubMed ID: 16952561
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic evaluation of an animal model for Barrett's esophagus and adenocarcinoma of the distal esophagus.
Buskens CJ; Hulscher JB; van Gulik TM; Ten Kate FJ; van Lanschot JJ
J Surg Res; 2006 Oct; 135(2):337-44. PubMed ID: 16926029
[TBL] [Abstract][Full Text] [Related]
11. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
13. Early HER2 dysregulation in gastric and oesophageal carcinogenesis.
Fassan M; Mastracci L; Grillo F; Zagonel V; Bruno S; Battaglia G; Pitto F; Nitti D; Celiento T; Zaninotto G; Fiocca R; Rugge M
Histopathology; 2012 Nov; 61(5):769-76. PubMed ID: 22882541
[TBL] [Abstract][Full Text] [Related]
14. Endomicroscopy in the evaluation of Barrett's esophagus.
Dunbar KB
Curr Opin Gastroenterol; 2011 Jul; 27(4):374-82. PubMed ID: 21597371
[TBL] [Abstract][Full Text] [Related]
15. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
Jankowski J; Hopwood D; Pringle R; Wormsley KG
Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
[TBL] [Abstract][Full Text] [Related]
17. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
[TBL] [Abstract][Full Text] [Related]
18. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
19. Insulin promotes HER2 signaling activation during Barrett's Esophagus carcinogenesis.
Arcidiacono D; Antonello A; Fassan M; Nucci D; Morbin T; Agostini M; Nitti D; Rugge M; Alberti A; Battaglia G; Realdon S
Dig Liver Dis; 2017 Jun; 49(6):630-638. PubMed ID: 28185837
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid-induced TNFR family-related receptor (GITR)-expression in tumor infiltrating leucocytes (TILs) is associated with the pathogenesis of esophageal adenocarcinomas with and without Barrett's mucosa.
von Rahden BH; Kircher S; Kafka M; Stuermer L; Reiber C; Gattenlöhner S; Germer CT; Grimm M
Cancer Biomark; 2010; 7(6):285-94. PubMed ID: 21694467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]